Navigation Links
Surgery Better Than Stents for Multiple Blockages
Date:1/23/2008

Fewer deaths, heart attacks found in 18-month study

WEDNESDAY, Jan. 23 (HealthDay News) -- Bypass surgery provides a lower risk of death and heart attacks than stents for people with blockages of at least two heart arteries, a large-scale study indicates.

The finding is far from the last word on the stent-versus-surgery debate in such cases, said study author Dr. Edward L. Hannan, associate dean for research at the State University of New York at Albany School of Public Health. "But there isn't any other study right now that is better than this," he added.

"Physicians need to inform patients about these results and need to engage in a dialogue that includes these findings to determine what is the proper treatment for multi-vessel disease," Hannan said.

Hannan and his colleagues studied the outcomes of more than 17,400 procedures for people with multiple blocked coronary arteries. The outcomes were consistently better in an 18-month follow-up for bypass surgery than for the artery-opening procedure called angioplasty followed by insertion of a drug-coated tube known as a stent.

For example, 92.1 percent of those who had surgery for three blocked arteries had no heart attacks and were alive, compared to 89.7 percent of those who got stents. For those with two blocked arteries, the comparable numbers were 94.5 percent for surgery and 92.5 for stent implants.

The study was not the kind of randomized, controlled trial regarded as the gold standard for medical research. It was observational, meaning that the researchers simply recorded what happened in medical practice rather than trying to control all the factors involved in choosing a treatment.

"But the randomized trials done in the past have not necessarily been better," Hannan said. "They were restricted to patients who were not very sick, and they also did not recognize that when you compare two treatments, some patients might not pref
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. One Surgery Often Enough for Peritonitis
2. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
3. Surgery for severe obesity saves lives
4. Some Epilepsy Patients Are Good Candidates for Surgery
5. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
6. Hypnosis Eases Pain of Breast Cancer Surgery
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. Minimally Invasive Heart Surgery Research Wins N.I.H. Award
9. Cosmetic Surgery & Exotic Brazil
10. Small Incisions Make Heart Valve Surgery Safer
11. Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Surgery Better Than Stents for Multiple Blockages
Surgery Better Than Stents for Multiple Blockages
(Date:11/23/2009)...constructive Surgery...In Brief is distributed mon...current journal news from the American Society of ...s highlighted here, or to arrange an interview wit...ions at (847) 228-9900 or media@plasticsurgery.org...2009 -- Yes, Plastic Surgeons Have Plastic Surgery...
(Date:11/23/2009)...-ThousandsofpeoplewithiPhoneshavealreadydownloaded...tesbettermanagetheirdiseasethroughabetterunderstan...managetheirbloodsugar.Nowit,sbecomeeveneasierthrou... RocheDiabetesCare,themakeroftheACCU-CHEK®lin...partneredwithMYLEstoneHealth,thedeveloperofGlucose...
(Date:11/23/2009)..., Reportlinker.comannouncesthatanewmarketresearch...w.reportlinker.com/p0165298/Childrens-Food-and-Dri...novation-2nd-Edition.html#utm_source=prnewswire&am..., Despitethegrowingattentionbeingpaidtotheworld,sa...groupthatcannotbeoverlooked.Childrenagedbetween5an...
(Date:11/23/2009)...G.Schwade,M.D.announcesthenewlyenhancedCyberKnifee...enterofMiami,( www.cyberknifemiami.com ). ,, ...dintensedoseofradiationthatkillscancercellswithnoi...lastfrom30minutestoonehour,andisusuallycompletedin...CenterintheSoutheasternU.S.,theMiamifacilityhasled...
(Date:11/23/2009)...rtlinker.comannouncesthatanewmarketresearchreporti...MarketTrends ,, http://www.reportlinker.com/...tm_source=prnewswire&utm_medium=pr&utm_cam...suchasSARS,outbreakoffluandbioterrorismhavefurther...ventingthespreadofinfections.Allthesefactorshaveco...
Breaking Medicine News(10 mins):Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 2Health News:ACCU-CHEK(R) Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy.com 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 2Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 3Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 4Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 5Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 6Health News:Reportlinker Adds Children's Food and Drinks in Europe - A Guide to Markets, Products and Innovation 2nd Edition 7Health News:Reportlinker Adds Hand Sanitizers - US Market Trends 2Health News:Reportlinker Adds Hand Sanitizers - US Market Trends 3Health News:Reportlinker Adds Hand Sanitizers - US Market Trends 4
...ishing a common stomach-dwelling bacterium makes t... Many people would benefit from chronic usage// of...ke aspirin and diclofenac. Not only do these drugs... drawback. They may lead to stomach bleeding and u...
...rts have long thought depression could be bad for ...erous it can be. Brenda Penninx, a US gerentologis...e of 55//- both with and without heart disease- fo...eart disease as were patients who weren't depresse...
...dark winter months motivate binge eating in certai...ersity of Irvine have been looking at the factors ...rders, where binge eating is a significant symptom...different from the comfort eating that many of us ...
...cing body temperature by just a few degrees minimi...hen the heart suddenly stops - cardiac arrest - th...d of oxygen. //Even if the person survives, they r... it after a cardiac arrest. Doctors in Vienn...
...do you know when someone who talks about suicide w... difficulty deciding which depressed patients need... they have found a way to assess risk: a blood tes... the final step. So says psychiatrist William Cory...
...unfrozen ready-to-eat meals could lead to the resu...d. Advances in freezing have made botulism a rare ...cientists, a new generation of ready-to-eat foods/...oking of foods, some botulism poisoning in recent ...
Other Medicine News:
(Date:11/23/2009)..., NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/-...(Nasdaq: RPTP ),todayannouncedresultsfromaPhase2bc...inebitartrate("DRCysteamine")inpatientswithnephrop...theUniversityofCalifornia,SanDiego("UCSD")GeneralC...,pharmacokineticsandpharmacodynamicsofasingledoseo...
(Date:11/23/2009)..., EMERYVILLE,Calif.,Nov.23/PRNewswire-FirstCa... )("NTI")announcedtodaythatitsboardofdirectorshasd...monstock,whichwillbepaidonDecember9,2009tostockhol...xtraordinarydividendfollowsstockholderapprovalofth...ionanddissolutionandanearlierextraordinarydividend...
(Date:11/20/2009)..., , WAYNE, Pa., Nov. 20 /PRNewswire-FirstCal...announced the results for its fiscal first quarter...uarter of fiscal 2010, product revenue decreased a...ng the three-month period ended September 30, 2009... The Company reported the decreased net revenue of...
Breaking Medicine Technology:Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Reminder program dramatically increases mammography rates Kaiser Permanente study finds 51578 1Reminder program dramatically increases mammography rates Kaiser Permanente study finds 51578 2Reminder program dramatically increases mammography rates Kaiser Permanente study finds 51578 3FAIR CEO Blasts Kaiser Foundation 26amp 3B Public Agenda HIV AIDS Study Results as 26quot 3BAbsolute Nonsense 26quot 3B 51573 1FAIR CEO Blasts Kaiser Foundation 26amp 3B Public Agenda HIV AIDS Study Results as 26quot 3BAbsolute Nonsense 26quot 3B 51573 2FAIR CEO Blasts Kaiser Foundation 26amp 3B Public Agenda HIV AIDS Study Results as 26quot 3BAbsolute Nonsense 26quot 3B 51573 3FAIR CEO Blasts Kaiser Foundation 26amp 3B Public Agenda HIV AIDS Study Results as 26quot 3BAbsolute Nonsense 26quot 3B 51573 4Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 1Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 2Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 3Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 4Eliminating polio requires global coordinated effort Health Affairs article highlights risks rewards of eradication 51569 5
...pr 16, 2007 - Amgen,(Nasdaq:AMGN) today presented ...bo-controlled Phase 3 study evaluating the,efficac...the,treatment of anemia in patients with active ca...the 103 study"). Aranesp is not,approved for use b... were presented in an oral session at the 2007 Ame...
...nt not met; plausibly,confounded by survival benef...K, April 16, 2007 /PRNewswire-FirstCall/ -- ImClon...mpany today,announced detailed results from the EP...Phase III trial - comparing ERBITUX(R),(Cetuximab)...ith,metastatic colorectal cancer (mCRC) who failed...
Other Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 2Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 3Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 4Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 5Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 6Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 7Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 8Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients 9
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Keeler Sport Frames
Medicine Products: